Purchase Order 75N95024P00615
Award Date 9/19/24
Potential Completion Date 9/18/29
Potential Value $1.5M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Buffalo, NY 14203, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health National Institute on Drug Abuse awarded a $288,375 firm fixed price purchase order to Curia Global Inc., doing business as Amri, to provide non-GMP synthesis of up to 100 ligands that bind the KIAA0203 protein. Under the terms of the contract, Amri will synthesize the ligands in 2-10 milligram quantities over a one-year period of performance. Amri must dedicate two full-time scientists and one part-time scientist at 25% effort to update progress. There is no...
- This is a $3,349,436.46 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc., doing business as AMRI. The contract is part of NINDS's Medicinal Chemistry Support Program for Therapeutic Development, which focuses on early-stage drug discovery research. The contract provides for exploratory chemistry and other pharmaceutical research and development services to support NINDS's scientific initiatives,...
- This is a federal contract award issued by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri). The contract is part of the Medicinal Chemistry Support Program for Therapeutic Development (MCSP) and has a task order number of NIH-NINDS-20-03. The contract is focused on "Medicinal Chemistry Support Program for Therapeutic Development" and specifically on the "BASE EC (PAIN)"...
- This is a delivery order award under the Drug Manufacturing and Formulation Program (DMFP) Indefinite Delivery/Indefinite Quantity (IDIQ) contract, which was awarded to Curia Global Inc. (doing business as Amri), a for-profit organization and manufacturer of goods. The award, valued at $3,140,340.00, is for the National Institute of Neurological Disorders and Stroke (NINDS), a civilian federal agency. The contract is a Cost Plus Fixed Fee type, with an ultimate completion date of September 16,...
- This is a delivery order contract awarded by the National Institute of Mental Health (NIMH) to Curia Global Inc., doing business as Amri, a leading contract development and manufacturing organization (CDMO). The contract is part of the Medicinal Chemistry Support Program for Therapeutic Development (MCSP) and is for exploratory chemistry research related to Alzheimer's disease. The contract has a ceiling value of $607,397.30 and a performance period ending on June 2, 2025. The contract is a...
- This is a task order awarded under the Drug Manufacturing and Formulation Program (DMFP) Indefinite Delivery/Indefinite Quantity (IDIQ) contract, which was awarded to the prime contractor Curia Global Inc. (doing business as Amri). The task order is for the administrative de-obligation of unexpended and expiring Fiscal Year 2020 funding, in preparation for the September 30, 2025 closing of the period of availability for these funds. The award has a ceiling value of $1,191,883.22 and is a Cost...
- The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $3,173,498.83 cost-plus-fixed-fee Delivery Order contract to Curia Global Inc., doing business as Amri, for Exploratory Chemistry services under the Medicinal Chemistry Support Program for Therapeutic Development. The contract has a completion date of February 1, 2026 and does not have a small business set-aside designation. Curia, a global contract...
- This is a delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc., doing business as Amri, for the Medicinal Chemistry Support Program for Therapeutic Development. The contract, with a potential value of $4,042,434.33, provides chemistry, manufacturing, and controls development; exploratory chemistry; hit-to-lead chemistry; absorption/distribution/metabolism/excretion testing; process...
- This $142,500 firm-fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Curia Global Inc., doing business as Amri, a global contract development and manufacturing organization (CDMO). The contract is for sequencing services to identify molecules that bind the KIAA0203 protein, in support of the NIH's preclinical drug discovery efforts. No set-aside designation was used. Curia has provided...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri) for $815,714.07. The contract is for medicinal chemistry services to support the "ALDRICH (UNIV. OF FLORIDA) - EXPLORATORY CHEMISTRY-ADMET ONLY - MCSP" project, which is part of NINDS's Medicinal Chemistry Support Program for therapeutic development. Curia, a...